ClariVest Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

ClariVest Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-103,300	Closed	-$754K	–	789
2018 Q3	$754K	Sell	103,300 -7,400	-7%	-$32.4K	0.01%	458
2018 Q2	$410K	Buy	110,700 +1,000	+0.9%	+$4.63K	0.01%	525
2018 Q1	$422K	Sell	109,700 -12,653	-10%	-$53.2K	0.01%	517
2017 Q4	$440K	Buy	122,353 +23,340	+24%	+$88.1K	0.01%	507
2017 Q3	$391K	Buy	99,013 +15,491	+19%	+$71.1K	0.01%	406
2017 Q2	$425K	Buy	83,522 +22,960	+38%	+$129K	0.01%	399
2017 Q1	$418K	Buy	60,562 +23,962	+65%	+$187K	0.01%	404
2016 Q4	$342K	Buy	36,600 +15,700	+75%	+$141K	0.01%	438
2016 Q3	$204K	Buy	+20,900	New	+$282K	0.01%	490

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

ClariVest Asset Management's AGTC Position: Q4 2018 in Review

ClariVest Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2018, closing a stake of 103,300 shares — an estimated $754K sold.

ClariVest Asset Management first reported a position in AGTC in Q3 2016 and held it in 9 quarters. The position peaked at $754K in Q3 2018. 54 funds tracked by Wall St. Rank hold AGTC as of Q4 2018.

ClariVest Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2018 after selling out during the quarter.
ClariVest Asset Management sold 103,300 Applied Genetic Technologies Corporation shares in Q4 2018, an estimated $754K.
ClariVest Asset Management first reported a position in Applied Genetic Technologies Corporation in Q3 2016 and held it in 9 quarters.
ClariVest Asset Management's Applied Genetic Technologies Corporation position peaked at $754K in Q3 2018.
54 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2018.

Based on ClariVest Asset Management's 13F filing for Q4 2018, filed 5 Feb 2019.